Steven D. Averbuch BS, MD

Dr. Averbuch is Vice President, Head of Precision Medicine, at Bristol-Myers Squibb. In this role, Steve leads integrated biomarker and pharmacodiagnostic activities across the BMS R & D portfolio. Dr. Averbuch joined Bristol-Myers Squibb in 2006 and he has led the Pharmacodiagnostics Center of Excellence since 2008.
His Other previous roles included: Leading the strategy, business development agreements and execution of external clinical collaborations for the company’s immuno-oncology pipeline; Executive sponsor and oversight for translational research activities for all late development and marketed oncology compounds; Leader of corporate-wide strategic initiatives for translational and targeted medicine; Co-leader of the oncology early strategy team, which included responsibility for the execution of Phase II oncology programs.